Award
Delivery Order #SPE2D226F1397
Supplemental Delivery Order for Indomethacin Capsules under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$23.44
Ceiling
$23.44
Awarded
February 28, 2026
Period of Performance
Feb 28, 2026 – Mar 02, 2026
Identifier
SPE2D226F1397
NAICS
325411
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) previously awarded to DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor specializing in supplying essential drug products to government agencies. The delivery order procures indomethacin capsules, a significant medication in the pharmaceutical supplies portfolio. The contract supports the government’s ongoing healthcare initiatives by ensuring prompt access to critical medications, thereby enhancing public health outcomes. The scope covers the short-term delivery of indomethacin capsules as specified in the longstanding IDV agreement. Awarded following the competitive bidding process of the parent contract, this supplemental order reflects the continued partnership between the agency and DMS Pharmaceutical Group. The contract’s timeline is brief, focusing on a multi-day delivery window in early 2026. No subcontractors or further previous contract details are reported for this specific order, but it builds upon the comprehensive pharmaceutical supply capacity established by the parent IDV starting mid-2025.
Description
8511950655!INDOMETHACIN CAPSUL